| Literature DB >> 35162773 |
Odontuya Dorj1,2, Chin-Kai Lin1,3, Eisner Salamanca1, Yu-Hwa Pan1,4,5,6, Yi-Fan Wu1, Yung-Szu Hsu1, Jerry C-Y Lin1,7, Hsi-Kuei Lin1,8,9, Wei-Jen Chang1,9.
Abstract
Few studies have compared marginal bone loss (MBL) around implant-retaining overdentures (IODs) vs. implant-supported fixed prostheses (FPs). This study evaluated the mean MBL and radiographic bone-implant interface contact (r-BIIC) around IODs and implant-supported FPs. We also investigated osseointegration and MBL around non-submerged dental implants. We measured the changes between the MBL in the mesial and distal sites immediately after prosthetic delivery and after one year. The mean MBL and its changes in the IOD group were significantly higher. The mean percentage of r-BIIC was significantly higher in the FP group. MBL and its changes in males were significantly higher in the IOD group. The percentage of r-BIIC was significantly higher in the FP group. MBL in the lower site in the IOD group was significantly higher. Regarding MBL, the location of the implant was the only significant factor in the IOD group, while gender was the only significant predictor in the FP group. Regarding the r-BIIC percentage, gender was a significant factor in the FP group. We concluded that non-submerged dental implants restored with FPs and IODs maintained stable bone remodeling one year after prosthetic delivery.Entities:
Keywords: implant-retained overdenture; implant-supported fixed prosthesis; marginal bone loss; non-submerged dental implant; radiographic bone-implant interface contact
Mesh:
Year: 2022 PMID: 35162773 PMCID: PMC8835213 DOI: 10.3390/ijerph19031750
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Vector illustration of the non-submerged dental implants (ITI Straumann implant). (A) MBL at mesial (M) and distal (D) sites. (B) AL, actual length of the implant; r-BIIC, radiographic bone-implant interface contact.
Demographic data and implant related information.
|
|
|
|
| |||
|
|
|
| ||||
| Age, mean (SEM) | 66.31 (2.54) | 48.07 (1.75) | ||||
| Gender ( | ||||||
| Male | 22 | 47.8% | 10 | 62.5% | 12 | 40.0% |
| Female | 24 | 52.2% | 6 | 37.5% | 18 | 60.0% |
|
|
|
|
| |||
| Location ( | ||||||
| Upper jaw | 18 | 30.0% | 7 | 23.3% | 11 | 36.7% |
| Lower jaw | 42 | 70.0% | 23 | 76.7% | 19 | 63.3% |
| Diameter ( | ||||||
| 3.3 mm | 6 | 10.0% | 6 | 20.0% | 0 | 0.0% |
| 4.1 mm | 29 | 48.3% | 22 | 73.3% | 7 | 23.3% |
| 4.8 mm | 25 | 41.7% | 2 | 6.7% | 23 | 76.7% |
| Length ( | ||||||
| 10 mm | 58 | 96.7% | 28 | 93.3% | 30 | 100.0% |
| 8 mm | 2 | 3.3% | 2 | 6.7% | 0 | 0.0% |
Note: IOD, implant-retaining overdentures; FP, implant-supported fixed prostheses. The table includes a total of 46 patients and 60 implants (For IODs, 11 patients received two implants, 1 four implants, and 4 one implant (they had one implant in the past), while 30 patients received 30 implants in the FP group).
Figure 2Marginal bone level alteration at baseline and 12-month follow-up after prosthetic delivery of implant-supported fixed protheses (FPs) and implant-retaining overdentures (IODs). (a) Mean MBL; (b) MBL in mesial site; and (c) MBL in distal site. A paired t-test was used. *** p < 0.001, ** p < 0.01 and * p < 0.05.
Marginal bone level alteration: Intra-group analysis of IODs and FPs.
| Time Period | IOD Group | FP Group |
|---|---|---|
| Average | ||
| Baseline | 0.62 ± 0.17 | 0.08 ± 0.03 |
| 12-month | 0.91 ± 0.16 | 0.18 ± 0.04 |
|
| <0.001 *** | <0.002 ** |
| Mesial site | ||
| Baseline | 0.52 ± 0.19 | 0.05 ± 0.02 |
| 12-month | 0.76 ± 0.15 | 0.10 ± 0.04 |
|
| 0.017 * | 0.061 |
| Distal site | ||
| Baseline | 0.72 ± 0.17 | 0.10 ± 0.04 |
| 12-month | 1.06 ± 0.20 | 0.25 ± 0.06 |
|
| 0.006 ** | 0.004 ** |
Note: Data presented as the mean ± SEM. Out of 60 implants, 30 were of the IOD group, and 30 were of the FP group. A paired t-test was used. *** p < 0.001, ** p < 0.01, and * p < 0.05.
Figure 3Marginal bone loss comparison between implant-supported fixed prostheses (FPs) and implant-retaining overdentures (IODs) at different time points. (a) Mean MBL; (b) MBL at the mesial site; and (c) MBL at the distal site. An unpaired t-test with Welch’s correction was used. *** p < 0.001, ** p < 0.01, and * p < 0.05.
Marginal bone level alteration: Inter-group analysis of IOD and FP.
| Time Period | IOD Group | FP Group | |
|---|---|---|---|
| Average | |||
| Baseline | 0.62 ± 0.17 | 0.08 ± 0.03 | 0.003 ** |
| 12-month | 0.91 ± 0.16 | 0.18 ± 0.04 | <0.001 *** |
| Mesial site | |||
| Baseline | 0.52 ± 0.19 | 0.05 ± 0.02 | 0.016 * |
| 12-month | 0.76 ± 0.15 | 0.10 ± 0.04 | <0.001 *** |
| Distal site | |||
| Before | 0.72 ± 0.17 | 0.10 ± 0.04 | 0.001 ** |
| 12-month | 1.06 ± 0.20 | 0.25 ± 0.06 | <0.001 *** |
Note: Data presented as the mean ± SEM. Out of 60 implants, 30 were of the IOD group, and 30 were of the FP group. An unpaired t-test with Welch’s correction was used. *** p < 0.001, ** p < 0.01 and * p < 0.05.
Figure 4Change in marginal bone loss comparison between implant-supported fixed protheses (FPs) and implant-retaining overdentures (IODs) after 12 months prosthetic delivery. An unpaired t-test was used. * p < 0.05.
Figure 5Radiographic bone-implant interface contact (r-BIIC) percentage comparison between the implant-supported fixed prostheses (FP) group and the implant-retained overdentures (IOD) group at 12 months after the prosthetic delivery. *** p < 0.001.
The effect of implant parameters on osseointegration and marginal bone level outcomes at the 12-month follow-up in the implant-supported fixed prostheses and implant-retaining overdenture groups according to gender.
| Index | Gender |
| IOD Group |
| FP Group |
|
|---|---|---|---|---|---|---|
|
|
| 17 | 0.91 ± 0.12 | 12 | 0.03 ± 0.02 | <0.001 *** |
|
| 13 | 0.92 ± 0.35 | 18 | 0.28 ± 0.06 | 0.092 | |
|
|
| 17 | 0.34 ± 0.11 | 12 | 0.03 ± 0.02 | 0.015 * |
|
| 13 | 0.22 ± 0.07 | 18 | 0.15 ± 0.04 | 0.383 | |
|
|
| 17 | 95.40 ± 0.99 | 12 | 99.75 ± 0.25 | <0.001 *** |
|
| 13 | 97.24 ± 0.53 | 18 | 98.50 ± 0.42 | 0.077 |
Note: Data presented as the mean ± SEM. n indicates the number of implants. MBL, marginal bone level; MBLC, marginal bone level change; r-BIIC, radiographic bone-implant interface contact. Out of 60 implants, 30 were of the IOD group, and 30 were of the FP group. An unpaired t-test with Welch’s correction was used. *** p < 0.001, and * p < 0.05.
The effect of implant parameters on osseointegration and marginal bone level outcomes at the 12-month follow-up in the implant-supported fixed prostheses and overdenture groups according to the lower site.
| Index | Location |
| IOD Group |
| FP Group |
|
|---|---|---|---|---|---|---|
|
| Lower jaw | 23 | 1.16 ± 0.14 | 19 | 0.13 ± 0.04 | <0.001 *** |
|
| Lower jaw | 23 | 0.28 ± 0.09 | 19 | 0.12 ± 0.04 | 0.115 |
|
| Lower jaw | 23 | 96.08 ± 0.79 | 19 | 98.79 ± 0.43 | 0.005 ** |
Note: Data presented as the mean ± SEM. n indicates the number of implants. MBL, marginal bone level; MBLC, marginal bone level change; r-BIIC, radiographic bone-implant interface contact. An unpaired t-test with Welch’s correction was used. *** p < 0.001, and ** p < 0.01.
The effect of implant parameters on osseointegration and marginal bone level outcomes at the 12-month follow-up in the implant-supported fixed prostheses and overdenture groups according to length.
| Index | Length |
| IOD Group |
| FP Group |
|
|---|---|---|---|---|---|---|
|
| 10 mm | 28 | 0.90 ± 0.17 | 30 | 0.18 ± 0.04 | <0.001 *** |
|
| 10 mm | 28 | 0.26 ± 0.07 | 30 | 0.10 ± 0.03 | 0.036 * |
|
| 10 mm | 28 | 96.50 ± 0.54 | 30 | 99.00 ± 0.29 | <0.001 *** |
Note: Data presented as the mean ± SEM. n indicates the number of implants. MBL, marginal bone level; MBLC, marginal bone level change; r-BIIC, radiographic bone-implant interface contact. An unpaired t-test with Welch’s correction was used. *** p < 0.001, and * p < 0.05.
The effect of patient and implant parameters on osseointegration and marginal bone level outcomes at the 12-month follow-up in the overdenture group (n = 30).
| Characteristics | MBL (mm) |
| MBLC (mm) |
| r-BIIC |
|
|---|---|---|---|---|---|---|
|
| ||||||
| Male | 0.91 ± 0.12 | 0.970 | 0.34 ± 0.11 | 0.391 | 95.40 ± 0.99 | 0.115 |
| Female | 0.92 ± 0.34 | 0.22 ± 0.07 | 97.24 ± 0.53 | |||
|
| ||||||
| Upper jaw | 0.09 ± 0.41 | 0.042 * | 0.32 ± 0.09 | 0.797 | 96.59 ± 0.72 | 0.639 |
| Lower jaw | 1.16 ± 0.14 | 0.28 ± 0.09 | 96.08 ± 0.79 |
Note: Data presented as the mean ± SEM. n indicates the number of implants. The male group had 17 implants; 13 for the female group. Seven implants were placed in the upper jaw, whereas 23 were in the lower jaw group. An unpaired t-test with Welch’s correction and a Welch ANOVA test was used. * p < 0.05.
The effect of patient and implant parameters on osseointegration and marginal bone levels at the 12-month follow-up in the implant-supported fixed prostheses group. (.
| Parameter | MBL |
| MBLC (mm) |
| r-BIIC |
|
|---|---|---|---|---|---|---|
|
| ||||||
| Male | 0.03 ± 0.03 | 0.001 | 0.03 ± 0.03 | 0.018 * | 99.75 ± 0.25 | 0.018 * |
| Female | 0.28 ± 0.06 | 0.15 ± 0.04 | 98.50 ± 0.42 | |||
|
| ||||||
| Upper jaw | 0.25 ± 0.09 | 0.293 | 0.06 ± 0.03 | 0.272 | 99.36 ± 0.27 | 0.272 |
| Lower jaw | 0.13 ± 0.04 | 0.12 ± 0.04 | 98.79 ± 0.43 | |||
|
| ||||||
| 4.1 mm | 0.13 ± 0.06 | 0.483 | 0.13 ± 0.06 | 0.620 | 98.71 ± 0.64 | 0.620 |
| 4.8 mm | 0.19 ± 0.05 | 0.09 ± 0.03 | 99.09 ± 0.33 |
Note: Data presented as the mean ± SEM. n indicates the number of implants. The male group had 12 implants, while 18 for the female group. Eleven implants were placed in the upper jaw, whereas 19 were in the lower jaw group. 7 and 23 implants were 4.1 mm, and 4.8 mm wide, respectively. However, out of 30 implants, 30 implants were 10 mm long. An unpaired t-test with Welch’s correction. * p < 0.05.